Global Advanced Therapy Medicinal Products Market
Pharmaceuticals

How Will The Advanced Therapy Medicinal Products Market Expand At A CAGR Of 19.4% Through 2029?

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Advanced Therapy Medicinal Products Market?

The market size of advanced therapy medicinal products has experienced a significant surge in the past few years. Projections show that from $42.85 billion in 2024, it is expected to climb to $51.34 billion in 2025, boasting a compound annual growth rate (CAGR) of 19.8%. Factors contributing to the growth during the historical period include an increase in the number of clinical trials for gene and cell therapies, the escalating occurrence of unique and genetic diseases, a growing preference for curative treatments over managing chronic illnesses, improvements in success rates of initial phase clinical studies, and the increasing incidence of chronic and age-related ailments.

The market size of advanced therapy medicinal products is anticipated to undergo substantial expansion in the forthcoming years, escalating to $104.43 billion in 2029 with a compound annual growth rate (CAGR) of 19.4%. Factors pushing this growth during the forecasted period encompass the escalating demand for precision and personalized medicine methods, a burgeoning pipeline of chimeric antigen receptor t-cell and gene-editing therapies, the rising implementation of precision medicine and genomics, amplified healthcare spending in rising markets, and an increased emphasis on decentralized clinical trial models. Noteworthy tendencies in the forecasted period incorporate the advancement of allogeneic off-the-shelf therapies, the development of non-viral gene delivery vectors, the assimilation of digital twins in therapy simulation, the utilization of blockchain in supply chain tracking, and the innovation of 3D bioprinting for tissue engineering.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp

What Drivers Are Accelerating Expansion Of The Advanced Therapy Medicinal Products Market?

The anticipated growth of the advanced therapy medicinal products market is being driven by the increasing demand for personalized medicine. This type of medical treatment is customized to an individual’s unique genetic makeup, lifestyle, and environment. The need for personalized medicine is predominantly fueled by the widespread occurrence of chronic diseases, as it allows for bespoke treatments which enhance patient outcomes and minimize side effects. Advanced therapy medicinal products facilitate this by providing custom treatments, including gene, cell, and tissue-engineered therapies designed to target the specific genetic and biological characteristics of individual patients. The Personalized Medicine Coalition, a non-profit organization in the US, announced in February 2024 that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, an increase from just six in 2022. The FDA approvals for 2023 also included seven cancer treatments and three for other diseases and conditions. Accordingly, the increasing demand for personalized medicine stimulates the expansion of the advanced therapy medicinal products market.

What Are The Primary Segmentation Parameters In The Advanced Therapy Medicinal Products Market?

The advanced therapy medicinal products market covered in this report is segmented –

1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products

2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes

3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy

2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes

3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies

Which Emerging Trends Are Reshaping The Advanced Therapy Medicinal Products Market Landscape?

Leading enterprises in the advanced therapeutic medicinal products marketplace are shifting their attention towards the creation of innovative treatments, such as novel car-t cell therapies. These advanced therapies aim to enhance treatment results in cancer and other severe illnesses by using the patient’s own T cells, which are genetically manipulated to identify and eliminate cancer cells. For example, in May 2022, Novartis AG, a pharmaceutical firm based in Switzerland, was granted approval by the U.S. Food and Drug Administration (FDA) for its car-t cell therapy, Kymriah. This therapy is designed to administer patients suffering from relapsed or refractory follicular lymphoma (FL) post two or more prior systemic treatments. The patient’s own T cells, reengineered to express a chimeric antigen receptor (CAR) that targets the cd19 protein, are utilized in this treatment. This alteration allows the T cells to identify and eradicate malignant B cells. Furthermore, Kymriah includes a 4-1BB costimulatory domain to encourage the expansion and persistence of T cells, thus ensuring a sustained antitumor effect from a single transfusion.

Which Players Are Shaping The Competitive Landscape Of The Advanced Therapy Medicinal Products Market?

Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-global-market-report

What Are The Emerging Regional Trends Driving The Advanced Therapy Medicinal Products Market?

North America was the largest region in the advanced therapy medicinal products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25689&type=smp

Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Market 2025, By The Business Research Company

Music Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Infectious Disease Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

Veterinary Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model